South Korean drugmaker Samsung Bioepis said Friday that global sales of five major biosimilar products increased 30 percent on-year in the first half of this year. Sales of the five biosimilar products during the first half reached $166 million, from $128 million from the same period a year earlier, according to an earnings report of its global pharmaceutical partner Organon International, a spinoff of US-based Merck. The five products are etanercept, infliximab, adalimumab, trastuzumab and

Technology Aug. 13, 2021

German material technology company Merck said Friday it has developed a new lineup of green solvents for use in photolithographic processes in semiconductor manufacturing. The new solvent lineup is called AZ 910 Remover, which according to the firm is N-methylpyrrolidone-free solvent designed for faster dissolution of photoresist patterns in a cost-effective and greener way with its outstanding resist-dissolution performance. Semiconductor production facilities traditionally use negative

Technology July 23, 2021

Merck, the cutting-edge material developer from Germany, said Thursday the company has started mass production of hole transport materials for organic light-emitting diode displays used in smartphones. Better known as HTM, the material is applied to common layers of OLED panels, and helps improve the efficiency and lifespan of panels, the company said. Merck, which has been supplying the material for Korea’s largest OLED panel maker LG Display for large-size displays, will expand its

Technology July 22, 2021

PARIS, July 13, 2021 /PRNewswire/ -- With a common vision of a world where no plastic waste ends up in nature – land or sea – The Consumer Goods Forum's (CGF) Coalition of Action on Plastic Waste today announces the latest critical step made by Coalition members to transform the industry's relationship with plastic packaging. The Coalition's 42 member companies have published the remaining seven "Golden Design Rules", which follows on from the launch of the first two of the series in

PR Newswire July 13, 2021

NEW YORK and HONG KONG, June 22, 2021 /PRNewswire/ -- Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million Series C financing led by Warburg Pincus. The financing was also participated by current investors including Qiming Venture Partners, Pavilion Capital, Eight Roads Ventures, Lilly Asia Ventures, Sinovation Ventures, BOLD Capital Partners, Formic Ve

PR Newswire June 22, 2021

Merck Korea is offering education on semiconductor and display solutions to local high school and college students studying related subjects, as part of its ESG initiative, the company said Thursday. According to the Korean unit of the science and technology company, the new education program comes after Kai Beckmann, member of the executive board of Merck and CEO of the Electronics, and Gyeonggi Province Gov. Lee Jae-myung agreed on a partnership in April. During their meeting, the two sid

Industry June 17, 2021

- Introduces new synthetic cholesterol product nine months ahead of schedule - Offers high purity, scalability, and consistent quality - One of a few companies that produces lipids in quantities needed to meet demand for mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine   DARMSTADT, Germany, May 26, 2021 /PRNewswire/ -- To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck, a leading science and technology company, has lau

PR Newswire May 26, 2021

-- A study on CNPharm's antiviral oral formulation published in a special edition of Pharmaceuticals -- Hyundai Bioscience to proceed to clinical trial with CP-COV03 SEOUL South Korea, May 24, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced on the 24th that CNPharm, its major shareholding bio tech company, published an article containing the research results of CP-COV03, a Niclosamide-based oral treatment for CO

PR Newswire May 24, 2021

⁃ New study indicating Niclosamide as 'COVID-19 game changer' was unveiled at Science Council of Asia Conference ⁃ World's first in vivo demonstration of antiviral efficacy of Niclosamide as oral formulation SEOUL, South Korea, May 13, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced that Dr. Jin-Ho Choi, a Chief Scientist of its major shareholding bio tech company CNPharm and Chair Professor at Dan

PR Newswire May 13, 2021

South Korea’s pharmaceutical and biopharma companies are ramping up efforts to get listed on the Nasdaq market, hoping to follow in the footsteps of Korean e-commerce giant Coupang with their US market debut. According to industry sources Thursday, CoImmune, a joint venture between SCM LifeScience and Genexine, is preparing for an initial public offering on the tech-heavy Nasdaq Composite. CoImmune’s appointment of biotechnology and finance expert Dr. Edgardo Baracchini to the co

Technology April 1, 2021

- € 25 million investment in Molsheim, France, will create 350 new jobs - Response to unprecedented global demand of key technology - Production capabilities anticipated to be operational by end of 2021 DARMSTADT, Germany, March 17, 2021 /PRNewswire/ -- Merck, a leading science and technology company, will add a single-use assembly production unit at its Life Science Center in Molsheim, France. With the € 2

PR Newswire March 18, 2021

Merck, the German science and technology group, said Friday it is changing the name of its performance materials business to electronics. The renaming is part of a strategic realignment it has made since 2018 under its “Bright Future” transformation program. “The renaming of our business sector to Electronics is a logical step for us,” said Kai Beckmann, member of the executive board of Merck and Electronics CEO. “After all, the new name underscores our strat

Technology March 5, 2021

Artiva Biotherapeutics, an affiliate of South Korean pharmaceutical firm Green Cross, announced Sunday that it has secured $120 million in Series B financing to develop natural killer (NK) cell-based cancer therapies. Artiva Biotherapeutics said its new investor Venrock Healthcare Capital Partners has led the latest financing. Other new investors include Acuta Capital Partners, Cormorant Asset Management, EcoR1 Capital, Franklin Templeton, according to the company. The injection of fresh cap

Technology Feb. 28, 2021

NeoImmuneTech, a US immunotherapy drug development company, said Monday that it was looking to raise as much as 96 billion won ($86.9 million) in fresh funds via an initial public offering on the South Korean bourse next month. Under the plan to be listed on Korea’s tech-heavy Kosdaq, NeoImmuneTech seeks to issue 15 million depository receipts in a price band between 5,400 won and 6,400 won. The exact share price will be determined through a book-building process for institutional investo

Market Feb. 22, 2021

German listed companies must include women on their executive boards as part of a landmark bill agreed by the country's coalition government Wednesday after voluntary efforts failed to close a gender gap. Listed companies with four executives or more must appoint at least one woman to their boards, according to a draft law to be voted on by parliament. The law sends "a very strong signal", Justice Minister Christine Lambrecht told reporters, urging corporations to "take advanta

World News Jan. 6, 2021

　Merck will invest 20 million euros ($23.6 million) in and around Pyeongtaek, Gyeonggi Province, to increase its organic light-emitting diode manufacturing capabilities, the company said Wednesday. 　The 20 million euros will be used to establish a modular production system for an additional OLED sublimation purification facility, and expand its OLED manufacturing facility in the neighboring county of Poseung-eup. 　OLED sublimation purification is a key step that ensures top-level OLED quality

Industry Oct. 28, 2020

Merck has been recognized with the Korea Bioprocessing Excellence Award at the Biologics Manufacturing Korea 2020 event, the company announced Thursday. The event, in its ninth year, annually invites some 400 experts from more than 100 governmental groups, nongovernmental organizations, related businesses and academic institutions to honor them in their respective categories. This year’s event was conducted virtually due to COVID-19. “Merck’s technology was recognized in the

Industry Oct. 22, 2020